Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Planning commission recommends approval of AstraZeneca building additions at 200 Orchard Ridge Drive with minor condition
Summary
The commission voted 4–0 to recommend approval of an amendment to the schematic development plan that allows three building additions totaling 7,988 square feet at AstraZeneca’s 200 Orchard Ridge Drive campus; commissioners asked staff to seek a clearer phasing plan at final site plan review.
The Gaithersburg Planning Commission on Aug. 6 recommended approval, 4–0, of an amendment to the schematic development plan (ASDP‑9990‑2024) to allow three additions totaling 7,988 square feet at 200 Orchard Ridge Drive on the AstraZeneca campus.
Planning staff presented the ASDP amendment for Building 200 and said the campus already includes approximately 818,000 square feet of office and research space, with about 103,000 square feet located at the 200 Orchard Ridge building. Carolyn Seiden, the staff presenter for the public hearing portion, said the amendment is to SDP 70592015, originally approved in October 2015 by resolution R‑82‑15, and that the application proposes site work including relocation of a loading area and modifications to adjacent surface parking.
Hannah Williams,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
